Following intrarenal injection of CHLA-255-Fluc or NGP-Fluc cells in mice and subsequent resection of the primary tumor, mice were treated with control (PBS), anti-CCL2 antibody alone, etoposide alone, or with the combination therapy of etoposide plus anti-CCL2 antibody. Here, CCL2 is linked to neoplasm.